This inventor holds 105 USPTO granted patents and 58 published patent applications, plus 19 CIPO patents and 45 EPO patents, primarily in Cystic Fibrosis Modulators (CPC class C07D405-12). Top assignees: Vertex Pharmaceuticals, Inc., Bristol-Myers Squibb Compnay, Bristol-Myers Squibb Pharma Company. Active years: 2004-2026.
Inventors with similar research interests:
Company Filing History:
102 out of 1,167 
2 out of 3,736 
1 out of 234 
Years Active: 2004-2026
Areas of Expertise:
Certainly! Here's an article about inventor Jinglan Zhou:
Title: The Innovative Mind of Jinglan Zhou: Pioneering Advancements in Cystic Fibrosis Treatment
Introduction:
In the bustling city of San Diego, California, resides the prolific inventor Jinglan Zhou, whose remarkable contributions have significantly impacted the field of pharmaceuticals. With an impressive portfolio of 94 patents to his name, Zhou stands out as a trailblazer in the realm of biomedical innovation.
Latest Patents:
Among Zhou's latest patents are groundbreaking discoveries in the realm of CFTR modulators. He has unveiled crystalline forms of Compound I, pharmaceutical compositions, and methods for treating cystic fibrosis. Additionally, Zhou has revolutionized the field with modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, and inventive treatment methods.
Career Highlights:
Zhou's illustrious career includes pivotal roles at renowned companies such as Vertex Pharmaceuticals, Inc., and Bristol-Myers Squibb Company. Through his work at these esteemed organizations, Zhou has spearheaded innovative projects that have reshaped the landscape of pharmaceutical research and development.
Collaborations:
A testament to his collaborative spirit, Zhou has worked alongside accomplished professionals in the field. Notable coworkers include Mark Thomas Miller and Jason McCartney, with whom Zhou has synergized efforts to drive forward transformative projects and create novel solutions for treating cystic fibrosis.
Conclusion:
In conclusion, Jinglan Zhou's remarkable journey as an inventor underscores his unwavering commitment to advancing healthcare through cutting-edge innovations. His prolific patent portfolio and groundbreaking discoveries serve as a testament to his ingenuity and dedication to improving the lives of individuals affected by cystic fibrosis. As Zhou continues to push the boundaries of scientific discovery, his contributions are set to leave a lasting impact on the field of pharmaceuticals for years to come.